respiratory viruses

MELBOURNE, Australia — September 15, 2026 ENA Respiratory announced that the first participants have been dosed in Part B...

LEIDEN, Netherlands — September 9, 2026 Leyden Laboratories B.V. announced positive Phase 1 results for RIG-101, supporting advancement of...

SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...

CAMBRIDGE, Mass. & HOUSTON, Feb. 5, 2026 — Decoy Therapeutics, Inc., a preclinical-stage biotechnology company developing next-generation peptide conjugate...